Viewing nowLipidstop Tablet 40 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
ILDONG Pharmaceutical Co., Ltd.

MFDS item code 200809045 · Notified 2008.08.28 · Insurance code 642903070
Improvement of hyperlipidemia, prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
This medication is used for the following purposes. Firstly, it helps to reduce the risk of cardiovascular diseases. In particular, it lowers the risk of myocardial infarction and stroke in adult patients with multiple risk factors for coronary heart disease and in patients with type 2 diabetes, and also decreases the risk of vascular surgery and angina. Additionally, it is effective in reducing the risk of nonfatal myocardial infarction, fatal and nonfatal stroke, vascular surgery, congestive heart failure hospitalization, and angina in patients with evidence of coronary heart disease. Furthermore, this medication is used for the treatment of hyperlipidemia, helping to lower total cholesterol, LDL cholesterol, Apo-B, and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia while raising HDL cholesterol levels. It is also used as an adjunct for the treatment of abnormal beta-lipoproteinemia and elevated serum triglycerides. In summary, this drug is used to reduce the risk of cardiovascular diseases and improve dyslipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This drug may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily. However, patients who require greater reductions in LDL cholesterol may start at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This drug is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this drug should be individualized according to patient characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, use of LDL cholesterol levels is recommended when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not feasible. ○ Patients with renal impairment: Renal disease does not affect atorvastatin plasma concentrations or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: Efficacy and safety in patients 70 years or older are generally similar to those in the general adult patient population.
This medication may cause muscle problems, so if symptoms of muscle pain or weakness occur, treatment should be stopped immediately and a doctor should be consulted. This medication should not be used in patients with severe liver impairment or active liver disease. Pregnant women or those who could become pregnant, as well as nursing mothers, should not take this medication. Regular liver function tests should be performed while taking this medication, and any symptoms of liver dysfunction should be reported to a doctor immediately. Elderly or patients with reduced kidney function may be more prone to muscle-related side effects from this medication, so careful monitoring is required. Drug interactions may occur when taken with other medications, so it is essential to inform the doctor or pharmacist of any current medications being taken. Particularly, caution is needed as the risk of muscle damage may increase when combined with certain antibiotics, antifungals, antivirals, and some lipid-lowering agents. This medication contains lactose, so patients with lactose intolerance should not take it. Children, especially those under 10 years of age, should not take this medication, while children over 10 years of age should take it under the guidance of a doctor. In case of overdose, there is no specific antidote, so treatment will be symptomatic, and management should include liver function and muscle enzyme tests. This medication should be kept out of reach of children and stored in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to protect it from air and moisture. The recommended storage temperature is between 1 to 30 degrees Celsius at room temperature.
White round film-coated tablet
30 tablets (10 tablets x 3) / PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
ILDONG Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.